DNM1L and chronic kidney disease: To sum up, our study demonstrated that silencing of Drp1 inhibited ROS/HIF-1α/EZH2 axis, all of which leads to the alleviation of hypercalcemia-induced neuronal injury following CKD (Fig. 7).